Back
Protagonist Therapeutics Vs. Semler Scientific Industry Stock Comparison
Sell
42
PTGX
Protagonist Therapeutics
Last Price:
44.91
Seasonality Move:
11.46%
Buy
71
SMLR
Semler Scientific
Last Price:
60.85
Seasonality Move:
16.9%
Sell
42
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $44.83. The Score for PTGX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Semler Scientific (SMLR)
is a Buy
Is Semler Scientific a Buy, Sell or Hold?
- The current Semler Scientific [SMLR] share price is $52.60. The Score for SMLR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- SMLR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $44.83
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
SMLR Stock Price Chart
What is Semler Scientific's stock price today?
-
The Semler Scientific share price today is $52.60
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMLR is experiencing selling pressure, which indicates risk of future bearish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.57 | Sell |
| Relative Strength Index (14 RSI): | 51.75 | Buy |
| Chaikin Money Flow: | -351807 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.15 - 47.79) | Sell |
| Bollinger Bands (100): | (38.65 - 46.37) | Buy |
SMLR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.67 | Buy |
| Relative Strength Index (14 RSI): | 58.58 | Buy |
| Chaikin Money Flow: | -1207553 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.31 - 54.47) | Buy |
| Bollinger Bands (100): | (22.29 - 40.83) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.41 | Buy |
| 20-day SMA: | 44.35 | Buy |
| 50-day SMA: | 45.19 | Sell |
| 200-day SMA: | 35.97 | Buy |
| 8-day EMA: | 43.68 | Buy |
| 20-day EMA: | 44.03 | Buy |
| 50-day EMA: | 44.11 | Buy |
| 200-day EMA: | 37.04 | Buy |
SMLR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.15 | Sell |
| 20-day SMA: | 45.89 | Buy |
| 50-day SMA: | 33.7 | Buy |
| 200-day SMA: | 31.91 | Buy |
| 8-day EMA: | 55.42 | Sell |
| 20-day EMA: | 47.8 | Buy |
| 50-day EMA: | 38.53 | Buy |
| 200-day EMA: | 32.98 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.44 per share.
Semler Scientific Earnings Growth & SMLR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.30 per share, and a decrease next year of $0.00 per share.
Protagonist Therapeutics Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Semler Scientific Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||